Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

First α-deuterium nitroxides; synthesis and EPR study.

Toledo H, Tumanskii B, Sabirov DS, Kaushansky A, Fridman N, Szpilman AM.

Org Biomol Chem. 2019 Aug 14. doi: 10.1039/c9ob01127g. [Epub ahead of print]

PMID:
31410426
2.

Synthesis of an Isolable Bis(silylene)-Stabilized Silylone and Its Reactivity Toward Small Gaseous Molecules.

Wang Y, Karni M, Yao S, Kaushansky A, Apeloig Y, Driess M.

J Am Chem Soc. 2019 Aug 14;141(32):12916-12927. doi: 10.1021/jacs.9b06603. Epub 2019 Aug 5.

PMID:
31337219
3.

Exciting Contributions to the Cryptosporidium Renaissance.

Vijayan K, Kaushansky A.

Cell Host Microbe. 2019 Jul 10;26(1):5-7. doi: 10.1016/j.chom.2019.06.008.

PMID:
31295425
4.

Spatial presentation of biological molecules to cells by localized diffusive transfer.

Regier MC, Olszewski E, Carter CC, Aitchison JD, Kaushansky A, Davis J, Berthier E, Beebe DJ, Stevens KR.

Lab Chip. 2019 Jun 11;19(12):2114-2126. doi: 10.1039/c9lc00122k.

PMID:
31111131
5.

Liver stage malaria infection is controlled by host regulators of lipid peroxidation.

Kain HS, Glennon EKK, Vijayan K, Arang N, Douglass AN, Fortin CL, Zuck M, Lewis AJ, Whiteside SL, Dudgeon DR, Johnson JS, Aderem A, Stevens KR, Kaushansky A.

Cell Death Differ. 2019 May 7. doi: 10.1038/s41418-019-0338-1. [Epub ahead of print]

PMID:
31065106
6.

Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection.

Glennon EKK, Austin LS, Arang N, Kain HS, Mast FD, Vijayan K, Aitchison JD, Kappe SHI, Kaushansky A.

Cell Rep. 2019 Mar 19;26(12):3391-3399.e4. doi: 10.1016/j.celrep.2019.02.085.

7.

A call to arms: Unifying the fight against resistance.

Kaushansky A, Hedstrom L, Goldman A, Singh J, Yang PL, Rathod PK, Cynamon M, Wodarz D, Mahadevan D, Tomaras A, Navia MA, Schiffer CA.

Sci Signal. 2018 Oct 23;11(553). pii: eaav0442. doi: 10.1126/scisignal.aav0442.

PMID:
30352947
8.

Next Generation Histology-Directed Imaging Mass Spectrometry Driven by Autofluorescence Microscopy.

Patterson NH, Tuck M, Lewis A, Kaushansky A, Norris JL, Van de Plas R, Caprioli RM.

Anal Chem. 2018 Nov 6;90(21):12404-12413. doi: 10.1021/acs.analchem.8b02885. Epub 2018 Oct 16.

PMID:
30274514
9.

Rhodium Complexes of a New-Generation Sapphyrin: Unique Structures, Axial Chirality, and Catalysis.

Chen QC, Saltsman I, Kaushansky A, Xiao ZY, Fridman N, Zhan X, Gross Z.

Chemistry. 2018 Nov 22;24(65):17255-17261. doi: 10.1002/chem.201804138. Epub 2018 Oct 30.

PMID:
30138537
10.

Opportunities for Host-targeted Therapies for Malaria.

Glennon EKK, Dankwa S, Smith JD, Kaushansky A.

Trends Parasitol. 2018 Oct;34(10):843-860. doi: 10.1016/j.pt.2018.07.011. Epub 2018 Aug 16. Review.

PMID:
30122551
11.

α-Sila-Dipeptides: Synthesis and Characterization.

Minkovich B, Ruderfer I, Kaushansky A, Bravo-Zhivotovskii D, Apeloig Y.

Angew Chem Int Ed Engl. 2018 Oct 1;57(40):13261-13265. doi: 10.1002/anie.201807027. Epub 2018 Sep 5.

PMID:
30117620
12.

Generation and Characterization of the First Persistent Platinum(I)-Centered Radical.

Kratish Y, Kostenko A, Kaushansky A, Tumanskii B, Bravo-Zhivotovskii D, Apeloig Y.

Angew Chem Int Ed Engl. 2018 Jul 2;57(27):8275-8279. doi: 10.1002/anie.201805107. Epub 2018 Jun 6.

PMID:
29763519
13.

Plasmodium yoelii S4/CelTOS is important for sporozoite gliding motility and cell traversal.

Steel RWJ, Pei Y, Camargo N, Kaushansky A, Dankwa DA, Martinson T, Nguyen T, Betz W, Cardamone H, Vigdorovich V, Dambrauskas N, Carbonetti S, Vaughan AM, Sather DN, Kappe SHI.

Cell Microbiol. 2018 Apr;20(4). doi: 10.1111/cmi.12817. Epub 2018 Jan 12.

PMID:
29253313
14.

The Promise of Systems Biology Approaches for Revealing Host Pathogen Interactions in Malaria.

Zuck M, Austin LS, Danziger SA, Aitchison JD, Kaushansky A.

Front Microbiol. 2017 Nov 16;8:2183. doi: 10.3389/fmicb.2017.02183. eCollection 2017. Review.

15.

Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles.

Arang N, Kain HS, Glennon EK, Bello T, Dudgeon DR, Walter ENF, Gujral TS, Kaushansky A.

Nat Commun. 2017 Nov 1;8(1):1232. doi: 10.1038/s41467-017-01345-2.

16.

Isolation and Characterization, Including by X-ray Crystallography, of Contact and Solvent-Separated Ion Pairs of Silenyl Lithium Species.

Pinchuk D, Mathew J, Kaushansky A, Bravo-Zhivotovskii D, Apeloig Y.

Angew Chem Int Ed Engl. 2016 Aug 22;55(35):10258-62. doi: 10.1002/anie.201603640. Epub 2016 Jul 28.

PMID:
27466152
17.

Malaria parasites target the hepatocyte receptor EphA2 for successful host infection.

Kaushansky A, Douglass AN, Arang N, Vigdorovich V, Dambrauskas N, Kain HS, Austin LS, Sather DN, Kappe SH.

Science. 2015 Nov 27;350(6264):1089-92. doi: 10.1126/science.aad3318.

18.

Flow Cytometry-Based Assessment of Antibody Function Against Malaria Pre-erythrocytic Infection.

Douglass AN, Metzger PG, Kappe SH, Kaushansky A.

Methods Mol Biol. 2015;1325:49-58. doi: 10.1007/978-1-4939-2815-6_4.

PMID:
26450378
19.

Host ER stress during malaria parasite infection.

Kaushansky A, Kappe SH.

EMBO Rep. 2015 Aug;16(8):883-4. doi: 10.15252/embr.201540792. Epub 2015 Jul 2. No abstract available.

20.

Selection and refinement: the malaria parasite's infection and exploitation of host hepatocytes.

Kaushansky A, Kappe SH.

Curr Opin Microbiol. 2015 Aug;26:71-8. doi: 10.1016/j.mib.2015.05.013. Epub 2015 Jun 21. Review.

21.

Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.

Mikolajczak SA, Vaughan AM, Kangwanrangsan N, Roobsoong W, Fishbaugher M, Yimamnuaychok N, Rezakhani N, Lakshmanan V, Singh N, Kaushansky A, Camargo N, Baldwin M, Lindner SE, Adams JH, Sattabongkot J, Kappe SH.

Cell Host Microbe. 2015 Apr 8;17(4):526-35. doi: 10.1016/j.chom.2015.02.011. Epub 2015 Mar 19.

22.

Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites.

Douglass AN, Kain HS, Abdullahi M, Arang N, Austin LS, Mikolajczak SA, Billman ZP, Hume JCC, Murphy SC, Kappe SHI, Kaushansky A.

Mol Ther. 2015 May;23(5):857-865. doi: 10.1038/mt.2015.18. Epub 2015 Feb 4.

23.

Systems biology of megakaryocytes.

Kaushansky A, Kaushansky K.

Adv Exp Med Biol. 2014;844:59-84. doi: 10.1007/978-1-4939-2095-2_4. Review.

PMID:
25480637
24.

Susceptibility to Plasmodium yoelii preerythrocytic infection in BALB/c substrains is determined at the point of hepatocyte invasion.

Kaushansky A, Austin LS, Mikolajczak SA, Lo FY, Miller JL, Douglass AN, Arang N, Vaughan AM, Gardner MJ, Kappe SH.

Infect Immun. 2015 Jan;83(1):39-47. doi: 10.1128/IAI.02230-14. Epub 2014 Oct 13.

25.

A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion.

Mikolajczak SA, Lakshmanan V, Fishbaugher M, Camargo N, Harupa A, Kaushansky A, Douglass AN, Baldwin M, Healer J, O'Neill M, Phuong T, Cowman A, Kappe SH.

Mol Ther. 2014 Sep;22(9):1707-15. doi: 10.1038/mt.2014.85. Epub 2014 May 14.

26.

Susceptibility to Plasmodium liver stage infection is altered by hepatocyte polyploidy.

Austin LS, Kaushansky A, Kappe SH.

Cell Microbiol. 2014 May;16(5):784-95. doi: 10.1111/cmi.12282. Epub 2014 Mar 28.

27.

Phosphorylated c-Mpl tyrosine 591 regulates thrombopoietin-induced signaling.

Sangkhae V, Saur SJ, Kaushansky A, Kaushansky K, Hitchcock IS.

Exp Hematol. 2014 Jun;42(6):477-86.e4. doi: 10.1016/j.exphem.2014.02.007. Epub 2014 Mar 4.

28.

Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites.

Finney OC, Keitany GJ, Smithers H, Kaushansky A, Kappe S, Wang R.

Vaccine. 2014 Apr 17;32(19):2135-8. doi: 10.1016/j.vaccine.2014.02.055. Epub 2014 Feb 28.

29.

Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections.

Kaushansky A, Mikolajczak SA, Vignali M, Kappe SH.

Cell Microbiol. 2014 May;16(5):602-11. doi: 10.1111/cmi.12277. Epub 2014 Mar 6. Review.

30.

Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum.

Sack BK, Miller JL, Vaughan AM, Douglass A, Kaushansky A, Mikolajczak S, Coppi A, Gonzalez-Aseguinolaza G, Tsuji M, Zavala F, Sinnis P, Kappe SH.

Infect Immun. 2014 Feb;82(2):808-17. doi: 10.1128/IAI.01249-13. Epub 2013 Dec 9.

31.

Malaria parasite liver stages render host hepatocytes susceptible to mitochondria-initiated apoptosis.

Kaushansky A, Metzger PG, Douglass AN, Mikolajczak SA, Lakshmanan V, Kain HS, Kappe SH.

Cell Death Dis. 2013 Aug 8;4:e762. doi: 10.1038/cddis.2013.286.

32.

Suppression of host p53 is critical for Plasmodium liver-stage infection.

Kaushansky A, Ye AS, Austin LS, Mikolajczak SA, Vaughan AM, Camargo N, Metzger PG, Douglass AN, MacBeath G, Kappe SH.

Cell Rep. 2013 Mar 28;3(3):630-7. doi: 10.1016/j.celrep.2013.02.010. Epub 2013 Mar 7.

33.

Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected.

Koytiger G, Kaushansky A, Gordus A, Rush J, Sorger PK, MacBeath G.

Mol Cell Proteomics. 2013 May;12(5):1204-13. doi: 10.1074/mcp.M112.025858. Epub 2013 Jan 28.

34.

Complete Plasmodium falciparum liver-stage development in liver-chimeric mice.

Vaughan AM, Mikolajczak SA, Wilson EM, Grompe M, Kaushansky A, Camargo N, Bial J, Ploss A, Kappe SH.

J Clin Invest. 2012 Oct;122(10):3618-28. doi: 10.1172/JCI62684. Epub 2012 Sep 10.

35.

Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites.

Kaushansky A, Rezakhani N, Mann H, Kappe SH.

Mol Biochem Parasitol. 2012 May;183(1):100-3. doi: 10.1016/j.molbiopara.2012.01.006. Epub 2012 Feb 8.

36.

The crucial role of hepatocyte growth factor receptor during liver-stage infection is not conserved among Plasmodium species.

Kaushansky A, Kappe SH.

Nat Med. 2011 Oct 11;17(10):1180-1; author reply 1181. doi: 10.1038/nm.2456. No abstract available.

37.

Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling.

Jung AS, Kaushansky A, Macbeath G, Kaushansky K.

Cell Cycle. 2011 Jun 1;10(11):1838-44. Epub 2011 Jun 1.

38.

Tyrosine-phosphorylated caveolin-1 blocks bacterial uptake by inducing Vav2-RhoA-mediated cytoskeletal rearrangements.

Boettcher JP, Kirchner M, Churin Y, Kaushansky A, Pompaiah M, Thorn H, Brinkmann V, Macbeath G, Meyer TF.

PLoS Biol. 2010 Aug 24;8(8). pii: e1000457. doi: 10.1371/journal.pbio.1000457.

39.

Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1.

Mehlitz A, Banhart S, Mäurer AP, Kaushansky A, Gordus AG, Zielecki J, Macbeath G, Meyer TF.

J Cell Biol. 2010 Jul 12;190(1):143-57. doi: 10.1083/jcb.200909095.

40.

Quantifying protein-protein interactions in high throughput using protein domain microarrays.

Kaushansky A, Allen JE, Gordus A, Stiffler MA, Karp ES, Chang BH, MacBeath G.

Nat Protoc. 2010 Apr;5(4):773-90. doi: 10.1038/nprot.2010.36. Epub 2010 Apr 1.

41.

Linear combinations of docking affinities explain quantitative differences in RTK signaling.

Gordus A, Krall JA, Beyer EM, Kaushansky A, Wolf-Yadlin A, Sevecka M, Chang BH, Rush J, MacBeath G.

Mol Syst Biol. 2009;5:235. doi: 10.1038/msb.2008.72. Epub 2009 Jan 20.

42.

System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.

Kaushansky A, Gordus A, Budnik BA, Lane WS, Rush J, MacBeath G.

Chem Biol. 2008 Aug 25;15(8):808-17. doi: 10.1016/j.chembiol.2008.07.006.

43.

A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R.

Kaushansky A, Gordus A, Chang B, Rush J, MacBeath G.

Mol Biosyst. 2008 Jun;4(6):643-53. doi: 10.1039/b801018h. Epub 2008 Apr 8.

44.

Correction of combined angular and rotational deformities by the Ilizarov method.

Shtarker H, Volpin G, Stolero J, Kaushansky A, Samchukov M.

Clin Orthop Relat Res. 2002 Sep;(402):184-95.

PMID:
12218483
45.

A structure-function analysis of serine/threonine phosphorylation of the thrombopoietin receptor, c-Mpl.

Miyakawa Y, Drachman JG, Gallis B, Kaushansky A, Kaushansky K.

J Biol Chem. 2000 Oct 13;275(41):32214-9.

46.

Benign abducens nerve palsy of childhood.

Cohen HA, Nussinovitch M, Ashkenazi A, Straussberg R, Kaushansky A.

Pediatr Neurol. 1993 Sep-Oct;9(5):394-5.

PMID:
8292216
47.

Endocrine studies of the ovulatory disturbances in Wilson's disease (hepatolenticular degeneration).

Kaushansky A, Frydman M, Kaufman H, Homburg R.

Fertil Steril. 1987 Feb;47(2):270-3.

PMID:
3817173
48.

Nocturnal enuresis: a familial condition.

Elian M, Elian E, Kaushansky A.

J R Soc Med. 1984 Jun;77(6):529-30. No abstract available.

49.

Endocrine and reproductive repercussions of immunization against progesterone and oestradiol in female rats.

Kaushansky A, Bauminger S, Koch Y, Lindner HR.

Acta Endocrinol (Copenh). 1977 Apr;84(4):795-803.

PMID:
576763
50.

[Editorial: Asplenia].

Kaushansky A, Elian E.

Harefuah. 1973 Nov 1;85(9):423-4. Hebrew. No abstract available.

PMID:
4776005

Supplemental Content

Loading ...
Support Center